Tag | Content |
---|
EnhancerAtlas ID | HS161-03995 |
Organism | Homo sapiens |
Tissue/cell | PC3 |
Coordinate | chr12:104996890-104998910 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOSL1 | MA0477.1 | chr12:104998079-104998090 | GATGAGTCACC | - | 6.32 | JUND | MA0491.1 | chr12:104998079-104998090 | GATGAGTCACC | - | 6.62 | Twist2 | MA0633.1 | chr12:104997162-104997172 | AACATATGGT | - | 6.02 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_09142 | chr12:104993485-105000794 | CD14 | SE_49965 | chr12:104985036-104999202 | RPMI-8402 | SE_66484 | chr12:104996408-104999292 | Jurkat |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH12I104602 | chr12 | 104996530 | 105000777 |
|
Enhancer Sequence | TCAGTGGGGA ATTTGATAGT TGGGTTCCCT TTGGTGCCCA AAAAATCTCC ATATTATAGG 60 CAGGTCTCCC AGCCTGTCCA CACACACCCT GTCCTAAGGA AGAGGCAGAA CTGTGCTTCA 120 ACAAAGGATA GGATTTCTGG TAACCCGTGT CAAAAACAAC ACAGGCTCCT CAGATGCAAA 180 CCATTCCCTT CTTTTTGTTG ATATCCTCTG TTCTCAGATG ATTTTCTCCT TCAAAACAAA 240 ACTACTGAAA CACTGCTGCA AATTTTATGG GTAACATATG GTGTCATGGG AAAAGCTATA 300 TCTGAAGTCA CCGCCCCTGT GGATGGAAGG TCCATGGACT GCGTCTGTCC TGTTCACTGT 360 TGGCTCCTCA GTACCTAACA CAGGGCTCTC AAATACTTGT GATTCAAAAC ATGAAAGTCC 420 AGGTTCAAAT CCCGGCTTCA TCTCTAACTA GTTGTGCAAC CCTGAATATA TGATGAGTTA 480 TCTTTAGGGG TCAGTTTTCC TACCTAAAAC TCTCCCTGGA ATGTTGGGAG GATGAAATAA 540 TTCTGATGTG TCAGGGGCTC TGTCAGTATG ATTTGTCATT TTTGTGGTCA GGAGGGTGGC 600 TTCCATATCA GAAGCCTTGA CTTAGGAGTC AGACCTGGGT TCAAAGCCTA GTTTCATCAT 660 TTCTTAGCTA TGTGACTATG GGGTGTTTAC TTAACCTCTC TGAGATTTCT TTCCTTGATT 720 TATAATGTGG CATGAGCAAT ACCTGCCTTG CAGTGTTGCA TGTGGTGATG TGTCTTGCTT 780 GGAGCTTCCT GTGGAGTTTG CTCCTTCATG GGTTCATTCA CTCCTTTTTT TCATTCATTT 840 CTTCATGTGC TGTTACATGT ACCTAGGAAC ATATAGCTTA GTAGCTTAGC AGCTTAGCAC 900 TAGGCGCTGG GCACAAAAGG GTGGAGAGGG TGTGTGCTTA GCCTTTTGTG GCTGGTAACT 960 CTGGGCCCAG AGTTGAGGGG AATGATTTGA CTGGCGAGGC AGACTCTGCT TGGTCCCATT 1020 GTAAACCAGT CATAGAAGAG ATGCCTGTCC TGGGTAGGGG CCCTCTCTTC CTTCCGGTAG 1080 TGTTCTGAGC ATTGTCTGGA TGACAGGCCT ATTGAGCAGT AGCCTGGGAC TTGGGAGGGA 1140 AACTAGGGCT GGAGAGCAGC TCTGGGAGGC ATTGGGGAGG GCGTAGGTGG ATGAGTCACC 1200 ATCCTCCCTC AAGGACGTCT TGGGCAAGTT GTCTGGCCCC ATTAGCCAGC AACCAGGGAA 1260 ATGTAGCTGC AGGAAAATCA CCTCGTTTCC TCGGGATGTT TTTTCTTAGG CTGGTTTCCT 1320 TTACAAGCTG CAATTATGTT CCATCCCACG CAAGTTCAGT AAGTGGCACT TTTCAGAGAA 1380 ACTGTCTTGG TGATCATTTG GGCTGCTGTG GGCCAGGGAG TTGAGGAGAG AAGGGAGTGA 1440 GAGCTTCTAC TGAGTTTAGT TGGTTTTGTG TCCATGAGCC ATTTACAAAC TTTGCACCTG 1500 ATTGGGCTCA GTTGCAGTTT CTTGTATTTC CCTACCAGCC AAGCTGTTGA AGCTGCTGAG 1560 CCCGGAATGA TGTTATCACT GAGGCAGATG ACAAACCCTC TAGTTGCTAG AAACCAAACT 1620 GCTCCCCGAG CTGGTGTTTC CGTTTTTTGT ACTGACTGCT TATTTGGGCT TGATATATAA 1680 TGGTGAAAAC AGGAACTGTT TATTTTAGGT GATAAGAAAC CAACATTATG ACAAGAAGAT 1740 GTCATCTTAG TTACTCTGTT ACCAGTACCA TAGGCCAGAT ACTATCTAGA TGCTTATAAA 1800 CATCTTATCT AATCCTTGTA ATAATAAGCC CCAAGCTAGG TTTTATATCC CCATTTTATG 1860 GATGGGGGAA CTGAGGCCAA TAACTTCATA TAACTTATCC AAGGCCACAA AACTAGTAAT 1920 AAACAGAGTG AAATTCAACC CAAAAACAAA CTACAAATCC AAATTTCTTT ACCTCTATGC 1980 TGTCTGTACT TGCTGTTACT AGCAAAGTTC TCTTGGTGGG 2020
|